Profile
Full Name
Avalo Therapeutics, Inc.Ticker Symbol
AVTXExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
October 14, 2015Indexes
Not includedWebsite
http://www.avalotx.comEmployees
23Key Details
Price
$4.90(-0.81%)
Market cap
$52.29M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$441.00K(-77.08% YoY)
Annual EPS
-$20.91(+81.59% YoY)
PE ratio
-
Next earnings date
May 13, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Avalo Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 25, 25 Stifel
BuyMar 25, 25 Jefferies
BuyMar 20, 25 HC Wainwright & Co.
NeutralFeb 28, 25 Piper Sandler
OverweightDec 19, 24 BTIG
BuyDec 17, 24 LUCID CAPITAL MARKETS
BuyOct 24, 24 HC Wainwright & Co.
NeutralApr 16, 24 Oppenheimer
OutperformJun 27, 23 RBC Capital
Sector PerformJun 27, 23 Oppenheimer
PerformInstitutional Ownership
- What is the ticker symbol for Avalo Therapeutics?
- Does Avalo Therapeutics pay dividends?
- What sector is Avalo Therapeutics in?
- What industry is Avalo Therapeutics in?
- What country is Avalo Therapeutics based in?
- When did Avalo Therapeutics go public?
- Is Avalo Therapeutics in the S&P 500?
- Is Avalo Therapeutics in the NASDAQ 100?
- Is Avalo Therapeutics in the Dow Jones?
- When was Avalo Therapeutics's last earnings report?
- When does Avalo Therapeutics report earnings?
- Should I buy Avalo Therapeutics stock now?
What is the ticker symbol for Avalo Therapeutics?
The ticker symbol for Avalo Therapeutics is NASDAQ:AVTX
Does Avalo Therapeutics pay dividends?
No, Avalo Therapeutics does not pay dividends
What sector is Avalo Therapeutics in?
Avalo Therapeutics is in the Healthcare sector
What industry is Avalo Therapeutics in?
Avalo Therapeutics is in the Biotechnology industry
What country is Avalo Therapeutics based in?
Avalo Therapeutics is headquartered in United States
When did Avalo Therapeutics go public?
Avalo Therapeutics's initial public offering (IPO) was on October 14, 2015
Is Avalo Therapeutics in the S&P 500?
No, Avalo Therapeutics is not included in the S&P 500 index
Is Avalo Therapeutics in the NASDAQ 100?
No, Avalo Therapeutics is not included in the NASDAQ 100 index
Is Avalo Therapeutics in the Dow Jones?
No, Avalo Therapeutics is not included in the Dow Jones index
When was Avalo Therapeutics's last earnings report?
Avalo Therapeutics's most recent earnings report was on Mar 20, 2025
When does Avalo Therapeutics report earnings?
The next expected earnings date for Avalo Therapeutics is May 13, 2025
Should I buy Avalo Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions